RRPV: Assay Development for Superior Understanding of Response and Efficacy
Due: February 24, 2026 The ASSURE program aims to develop innovative, multiplexed, high-throughput, scalable, and sample sparing assays that provide comprehensive evaluation of an individual’s immune status as a response to either infection or vaccination. Read More